Circle Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Circle Wealth Management's NVS Position: Q1 2026 in Review
Circle Wealth Management reduced its Novartis (NVS) stake by 2.5% in Q1 2026, selling an estimated $20.5K and leaving 5,196 shares worth $794K. The position accounts for 0.01% of the portfolio, ranked #164.
Circle Wealth Management first reported a position in NVS in Q3 2020 and has held it in 23 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Circle Wealth Management held 5,196 shares of Novartis worth $794K as of Q1 2026.
- Circle Wealth Management sold 134 Novartis shares in Q1 2026, an estimated $20.5K.
- Novartis made up 0.01% of Circle Wealth Management's portfolio in Q1 2026, its #164 holding.
- Circle Wealth Management first reported a position in Novartis in Q3 2020 and has held it in 23 quarters since.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Circle Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.